Stryker Corporation $SYK is CWS Financial Advisors LLC’s Largest Position

CWS Financial Advisors LLC lowered its holdings in shares of Stryker Corporation (NYSE:SYK) by 3.6% in the first quarter, HoldingsChannel.com reports. The fund owned 243,176 shares of the medical technology company’s stock after selling 9,000 shares during the quarter. Stryker comprises about 20.5% of CWS Financial Advisors LLC’s investment portfolio, making the stock its biggest holding. CWS Financial Advisors LLC’s holdings in Stryker were worth $79,905,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Sankala Group LLC acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $26,000. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker during the 4th quarter worth approximately $26,000. United Financial Planning Group LLC acquired a new position in shares of Stryker during the 3rd quarter worth approximately $27,000. Atlas Capital Advisors Inc. purchased a new stake in Stryker in the 4th quarter valued at approximately $27,000. Finally, DJE Kapital AG purchased a new stake in Stryker in the 4th quarter valued at approximately $28,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling

In related news, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the transaction, the vice president directly owned 10,582 shares in the company, valued at approximately $3,247,298.34. This represents a 30.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total value of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. The trade was a 13.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 323,264 shares of company stock worth $100,659,489. 4.60% of the stock is owned by company insiders.

Stryker Stock Down 0.0%

SYK stock opened at $326.41 on Friday. The stock has a market capitalization of $125.13 billion, a P/E ratio of 37.78, a PEG ratio of 2.09 and a beta of 0.77. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. Stryker Corporation has a one year low of $281.00 and a one year high of $404.87. The company has a 50 day moving average price of $309.80 and a two-hundred day moving average price of $338.87.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. During the same period in the prior year, the company earned $2.84 EPS. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, sell-side analysts expect that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is presently 40.74%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Sanford C. Bernstein set a $410.00 price target on Stryker in a research report on Friday, May 1st. Wells Fargo & Company reduced their price objective on Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Evercore set a $355.00 price objective on Stryker in a research note on Friday, May 1st. Truist Financial reiterated a “hold” rating and set a $330.00 price objective (down from $380.00) on shares of Stryker in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 target price on shares of Stryker in a research note on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $395.33.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.